1. Home
  2. RXT vs NVCR Comparison

RXT vs NVCR Comparison

Compare RXT & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rackspace Technology Inc.

RXT

Rackspace Technology Inc.

HOLD

Current Price

$4.71

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

Logo NovoCure Limited

NVCR

NovoCure Limited

HOLD

Current Price

$17.16

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RXT
NVCR
Founded
1998
2000
Country
United States
Switzerland
Employees
N/A
N/A
Industry
EDP Services
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.2B
IPO Year
2020
2015

Fundamental Metrics

Financial Performance
Metric
RXT
NVCR
Price
$4.71
$17.16
Analyst Decision
Hold
Buy
Analyst Count
6
6
Target Price
$1.71
$28.08
AVG Volume (30 Days)
36.7M
1.4M
Earning Date
05-07-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
75.13
21.79
EPS
0.03
N/A
Revenue
$2,685,700,000.00
$655,353,000.00
Revenue This Year
N/A
$7.72
Revenue Next Year
$1.35
$6.74
P/E Ratio
$186.33
N/A
Revenue Growth
N/A
8.28
52 Week Low
$0.39
$9.82
52 Week High
$7.65
$19.25

Technical Indicators

Market Signals
Indicator
RXT
NVCR
Relative Strength Index (RSI) 53.04 55.67
Support Level $1.04 $12.66
Resistance Level $7.65 $18.80
Average True Range (ATR) 0.79 1.02
MACD -0.11 -0.24
Stochastic Oscillator 45.34 64.84

Price Performance

Historical Comparison
RXT
NVCR

About RXT Rackspace Technology Inc.

Rackspace Technology Inc is an end-to-end, hybrid, multi-cloud technology services company. It designs, builds, and operates its customers' cloud environments across all technology platforms, irrespective of technology stack or deployment model. The company's solutions include Application Services, Data, Colocation, Cloud, Managed Hosting, Professional Services, and Security and Compliance. It has two reportable segments: Private Cloud and Public Cloud. Maximum revenue is generated from the Public Cloud segment, which offers cloud solutions through managed services, elastic engineering, and professional services offerings for customer environments hosted on the AWS, Microsoft Azure, and Google Cloud public cloud platforms. Geographically, the company derives its key revenue from the U.S.

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a proprietary platform technology in the United States. Its business involves the development, manufacture, and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis, and other products and technologies for the treatment of Glioblastoma, Non-small cell lung cancer, and Pancreatic cancer. Geographically, the company derives the majority of its revenue from the United States and the rest from Germany, Japan, and other markets.

Share on Social Networks: